Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

Monday, 20 July 2009

Squalenoyl nanomedicines can work as effective prospective therapeutics

Nucleoside analogs like gemcitabine and cytarabine were merely considered to be powerful anti-cancer agents in the past but a recent study shows that they can prove out to be even more valuable with a simple chemical modification for treating varying forms of cancer.

A research team headed by Patrick Couvreur, Ph.D., at the CNRS in Châtenay-Malabry, France, was of the view that this new technique seems to be potential candidate when it comes to working with almost all possible kinds of nucleoside analogs. In addition to that, the technique also has the net effect of increasing the pharmacological behavior of compounds belonging to this class.

From News-Medical.Net:
A research team headed by Patrick Couvreur, Ph.D., at the CNRS in Châtenay-Malabry, France, found that attaching the molecule squalene to any one of several nucleoside analogs triggered a self-assembly process that creates nanoparticles that are stable in biological fluids. Squalene is a naturally occurring, water-insoluble compound involved in synthesizing steroid hormones. Linking this molecule to a water-soluble nucleoside analog causes the resulting conjugates to form a core-shell nanostructure, with the nucleoside analogs creating an outer layer that shields the squalene portion from the surrounding aqueous environment.

Tests using cultured tumor cells showed that a squalene-gemcitabine conjugate was up to eight times more potent as an anticancer agent compared to unmodified gemcitabine. In addition, these in vitro studies showed that the squalene-gemcitabine conjugate was able to kill cells that had developed resistance to gemcitabine. The researchers attribute the improved anticancer activity, in both normal and resistant cells, to the fact that the conjugate is poorly metabolized by the enzymes that normally detoxify nucleoside analogs.

Based on these promising results, the investigators then assessed anticancer activity of squalene-modified gemcitabine in both mouse and rat models of human leukemia. In each case, 40 percent of the animals treated with the squalene-gemcitabine conjugate survived for at least 100 days after treatment. In contrast, control animals that received a placebo or unmodified gemcitabine all died from cancer within 60 days.
In other words, it was said that squalene-gemcitabine conjugate was potent by as much as eight times when compared to unmodified gemcitabine for treating varying forms of cancer.

Wednesday, 15 July 2009

Myth: Natural Medication always safe as alternative to Synthetic Medication

As per a research by a Consumer Reports magazine, the common perception that if a medication is natural then it must be safe is not completely true.

The research revealed that a large number of herbal supplements that are presently banned in Europe and Asia are freely available and used in the United States inspite of the fact that they can result in side-effects such as kidney or liver damage, cancer, and even death.

From News-Medical.Net:
The consumer publication found a dozen herbal supplements, some banned in Asia, Europe and Canada but widely available in the United States, may cause cancer, kidney or liver damage and even death. Those highlighted include:

Aristolochia, has received attention because of its alleged link to kidney damage and the onset of cancer. This herb was a part of a Chinese herbal compound, used in a weight reduction treatment regimen, in Belgium, in the early 1990s. By 1993, instances of kidney failure were documented in patients who had received treatment.

Yohimbe - which is a tree bark containing a variety of pharmacologically active chemicals. It is marketed in a number of products for body building and "enhanced male performance." Serious adverse effects, including renal failure, seizures and death, have been reported to FDA with products containing yohimbe and are currently under investigation.

Bitter orange, similar to ephedra, the banned weight-loss supplement believed responsible for 155 deaths nationwide.

The researchers also noted chaparral, comfrey, germander, kava and scullcap, all of which are known or likely causes of liver failure; lobella because of its impact on the heart; and pennyroyal oil because of possible liver, kidney and nerve damage.
The FDA has already sent warning letters to 16 dietary-supplement distributors in this regard along with an advice not to sell the bodybuilding supplement, androstenedione.